BioSpace News Archive

Kenergy Scientific Inc. is pleased to announce it has executed a Share Exchange agreement with “KNSC” and Florida based MedSmart Group, Inc. KNSC has acquired all of the issued and outstanding shares of MedSmart Group Inc. a Florida based medical wellness and antiaging centers focused on Men’s health.

- Phase 1/2 study of first-in-class inhibitor of RAD51-mediated homologous recombination advancing to once-daily dosing - Secrist, Gengos and Englert join Cyteir leadership team, enhancing company’s scientific, strategic business development, and drug development expertise

Today ProLynx announced it was awarded a Small Business Innovation Research (SBIR) grant from the NIH. The grant was conferred for the development of a long acting parathyroid hormone – PTH(1-34) – that can be administered once-weekly for treatment of hypo-parathyroidism. To achieve this, ProLynx will employ its platform half-life extension technology using its hydrogel microsphere carriers. The approved PTH replacement therapy is PTH(1-84), o

Medtronic plc (NYSE:MDT), the global leader in medical technology, today introduced the MiniMed™ Mio™ Advance infusion set to all Medtronic insulin pump customers in the United States. The MiniMed Mio Advance infusion set is the newest addition to the MiniMed™ portfolio of infusion sets and gives people using insulin pumps an optimal user experience with fewer steps 1 . The MiniMed Mio Advance infusion set is inserted in only four steps — individ

Vxtra Health, a new entry in the burgeoning health insurtech market announced today the appointment of Tim Attebery as chairman of the board. Recognized as one of the most innovative healthcare executives in America, Attebery joins the

Safety and efficacy endpoints met successfully in pivotal trial for F-627 (efbemalenograstim alfa), a novel long-acting G-CSF Key milestone and validation for Evive’s novel biologic development capability and technology platform Key component of the asset’s BLA submission to receive regulatory approval from the FDA Completes robust development program involving 10 succe

Neurogene Inc. , a company founded with a mission to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the U.S. Fo

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a publication in Contemporary Clinical Trials 1 , which details the design for “A P r ospective, Multi-c e nter, Randomized C ontrolled Blinded Trial Dem o nstrating the Safety and Effectiveness of V NS Therapy ® System as Adjunctiv e Therapy Versus a No Stimulation Control in Subjects With Treatment- R esistant Depres

US Food & Drug Administration (FDA) clears Servo-air® mechanical ventilator for use with adult and pediatric patients dependent on intensive care ventilation expanding upon the Servo family of products available in the United States for decades. “FDA 510(k) clearance for Servo-air will broaden our US offering with a turbi

Rakuten Medical, Inc. (Rakuten Medical) announced they have entered a multi-year deal with Merck KGaA, Darmstadt, Germany under which Merck KGaA, Darmstadt, Germany will provide cetuximab to Rakuten Medical for its ASP-1929 program. Rakuten Medical uses cetuximab in an intermediate form as the antibody component in its product c